This 8-K filing discloses an analyst's maintained 'Buy' rating and price target for Tilray Brands, along with details on recent share issuance and future growth drivers. The analyst's report highlights Tilray's Q1 share issuance to raise capital and management's expectation for reduced issuance as free cash flow improves, contingent on M&A activity. The BrewDog acquisition and Carlsberg licensing agreement are cited as key factors for renewed Adjusted EBITDA growth.
Roth Capital Partners maintained a 'Buy' rating on Tilray Brands (TLRY) with a US$9.00 price target, primarily due to an expected recovery in earnings. The filing reveals that Tilray issued 4.6 million shares in fiscal Q1, raising US$22.9 million through an at-the-market equity program. This share dilution is a short-term negative, but management indicated it should slow as free cash flow improves, which is a positive signal for long-term investors. The analyst also highlighted the BrewDog acquisition and an upcoming Carlsberg licensing agreement as catalysts for renewed Adjusted EBITDA growth, suggesting potential for future upside. Traders should monitor Tilray's free cash flow generation and any new M&A announcements, as these will dictate the pace of future share issuance and overall financial health.